Bridgebio Pharma, Inc. (BBIO) SEC Filings — 2025
13 SEC filings for Bridgebio Pharma, Inc. (BBIO) in 2025.
Filings
- BridgeBio Pharma Files 8-K for Other Events & Exhibits — 8-K · Oct 29, 2025
- BridgeBio Pharma Files 8-K on Financials — 8-K · Oct 29, 2025
- BridgeBio Pharma Files 8-K Report — 8-K · Oct 27, 2025
- BridgeBio's Q2 Loss Widens to $143.5M Amid R&D Surge — 10-Q · Aug 5, 2025
- BridgeBio Pharma Enters Material Definitive Agreement — 8-K · Jul 2, 2025
- BridgeBio Pharma Files 8-K on Shareholder Matters — 8-K · Jun 23, 2025
- BridgeBio Pharma Files Proxy Materials — DEFA14A · May 9, 2025
- BridgeBio Pharma Files 2025 Proxy Statement — DEF 14A · Apr 30, 2025
- BridgeBio Pharma Files Q1 2025 10-Q — 10-Q · Apr 29, 2025
- BridgeBio Pharma Files 8-K on Director/Officer Changes — 8-K · Mar 17, 2025
- BridgeBio Pharma Reports Material Agreements and Financial Updates — 8-K · Feb 28, 2025
- BridgeBio Pharma Files 8-K on Financials — 8-K · Feb 20, 2025
- BridgeBio Pharma Files 8-K on Financials and Operations — 8-K · Jan 13, 2025